Variceal haemorrhage is the most serious complication of portal hypert
ension and is associated with a high mortality rate. The first stage o
f treatment is to stabilize the patient, followed by emergency diagnos
tic endoscopy to identify the source of the bleeding. If active varice
al bleeding is found, endoscopic intervention is performed to induce h
aemostasis. The endoscopic techniques commonly used to treat bleeding
gastro-oesophageal varices include injection sclerotherapy and band li
gation. Sclerotherapy achieves haemostasis through the induction of th
rombosis or by external compression of the vessel and should be perfor
med during diagnostic endoscopy. Band ligation achieves haemostasis by
physical constriction of the varix. Band ligation may be less effecti
ve than sclerotherapy in the treatment of actively bleeding oesophagea
l varices and is therefore recommended for subsequent elective treatme
nt of non-bleeding varices. However, such techniques are difficult to
perform during active bleeding. This has prompted the search for impro
ved treatment protocols. Vasoactive drugs which lower portal hypertens
ion have been administered before, during and after endoscopy and may
offer an improvement in treatment. Data from several trials have sugge
sted that pharmacotherapy in combination with endoscopic intervention
is more effective than endoscopic treatment alone. Furthermore, pharma
cotherapy continued for 5 days following endoscopy significantly reduc
es the incidence of variceal rebleeding. A strict regimen for emergenc
y endoscopy should be used with sclerotherapy forming the basis of tre
atment-administered in combination with pharmacotherapy, to optimize c
linical outcome. However, there is still debate concerning what is the
most effective drug for treating variceal haemorrhage.